Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancer

Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancer

<h3>Background</h3><p dir="ltr">Immunotherapy has significantly improved outcomes for cancer patients; however, its clinical benefits vary among patients and its efficacy across breast cancer subtypes remains unclear. To enhance immunotherapy efficacy, it is important to...

Full description

Saved in:

Bibliographic Details
Main Author:	Adviti Naik (673163) (author)
Other Authors:	Remy Thomas (702843) (author), Aljazi Al-Khalifa (20905504) (author), Hanan Qasem (3337329) (author), Julie Decock (44558) (author)
Published:	2025
Subjects:	Biomedical and clinical sciences Clinical sciences Oncology and carcinogenesis LDHC Breast cancer Immune checkpoint Cytokines Chemokines
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy
by: Adviti Naik (673163)
Published: (2021)

Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
by: Remy Thomas (702843)
Published: (2020)

Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors
by: Adviti Naik (673163)
Published: (2020)

Commentary: Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer
by: A. Naik (7783220)
Published: (2023)

The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer
by: Adviti Naik (673163)
Published: (2019)

Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients
by: Shayista Akbar (14442117)
Published: (2023)

Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy
by: Ajaz A. Bhat (12984701)
Published: (2021)

Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment
by: Azharuddin Sajid Syed Khaja (19720105)
Published: (2017)

Next-generation nanoparticles for cancer and autoimmune therapy
by: Alshayma N. Al-Thani (17976380)
Published: (2025)

Blockade of PD-1, PD-L1, and TIM-3 Altered Distinct Immune- and Cancer-Related Signaling Pathways in the Transcriptome of Human Breast Cancer Explants
by: Reem Saleh (3513056)
Published: (2020)

DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
by: Varun Sasidharan Nair (5396393)
Published: (2018)

Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
by: Reem Saleh (3513056)
Published: (2019)

Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy
by: Ajaz A. Bhat (12984701)
Published: (2022)

Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
by: Reem Saleh (3513056)
Published: (2019)

Molecular profiling of the metaplastic spindle cell carcinoma of the breast reveals potentially targetable biomarkers
by: Semir, Vranic
Published: (2020)

Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients
by: Salman M. Toor (8854751)
Published: (2019)

Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential
by: Adviti Naik (673163)
Published: (2021)

The potential role of vitamin C in empowering cancer immunotherapy
by: Takwa, Bedhiafi
Published: (2022)

Tumor-Infiltrating Lymphoid Cells in Colorectal Cancer Patients with Varying Disease Stages and Microsatellite Instability-High/Stable Tumors
by: Salman M. Toor (8854751)
Published: (2021)

The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update
by: Maysaloun Merhi (4246147)
Published: (2023)

A collection of annotated and harmonized human breast cancer transcriptome datasets, including immunologic classification
by: Jessica Roelands (7516439)
Published: (2018)

Role of HMGB1 and its associated signaling pathways in human malignancies
by: Sourour, Idoudi
Published: (2023)

Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
by: Adviti Naik (673163)
Published: (2022)

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
by: Remy Thomas (702843)
Published: (2021)

The multiomics analyses of cancer stem cells isolated from solid tumors can provide insight for their immunological characterization.
by: Neha Gopinath (15431052)
Published: (2023)

The potential role of vitamin C in empowering cancer immunotherapy
by: Takwa Bedhiafi (14153460)
Published: (2022)

Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways
by: Kalyani Patil (2679424)
Published: (2022)

Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer
by: Reem Saleh (3513056)
Published: (2020)

B7-H3 at the crossroads between tumor plasticity and colorectal cancer progression: a potential target for therapeutic intervention
by: Elizabeth Varghese (11008845)
Published: (2023)

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
by: Remy Thomas (702843)
Published: (2018)

Comparison of Myeloid Cells in Circulation and in the Tumor Microenvironment of Patients with Colorectal and Breast Cancers
by: Salman M. Toor (8854751)
Published: (2017)

Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8+ Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients
by: Alhasan Alsalman (14802873)
Published: (2022)

Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
by: Afsheen Raza (492657)
Published: (2022)

The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers
by: Sarra Mestiri (14557379)
Published: (2024)

Myeloid cells in circulation and tumor microenvironment of breast cancer patients
by: Salman M. Toor (8854751)
Published: (2017)

Raising breast cancer awareness
by: Nature Research (16552612)
Published: (2015)

Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting
by: Shimaa Sherif (12862990)
Published: (2022)

Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts
by: Naushad Ahmad Khan (6406973)
Published: (2023)

Intratumoral FoxP3<sup>+</sup>Helios<sup>+</sup> Regulatory T Cells Upregulating Immunosuppressive Molecules Are Expanded in Human Colorectal Cancer
by: Azharuddin Sajid Syed Khaja (19720114)
Published: (2017)

CD56 expression in breast cancer induces sensitivity to natural killer-mediated cytotoxicity by enhancing the formation of cytotoxic immunological synapse
by: Ghina Taouk (14152767)
Published: (2019)